These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 12406560

  • 1. Unsaturated fatty acids bind Myc-Max transcription factor and inhibit Myc-Max-DNA complex formation.
    Chung S, Park S, Yang CH.
    Cancer Lett; 2002 Dec 15; 188(1-2):153-62. PubMed ID: 12406560
    [Abstract] [Full Text] [Related]

  • 2. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S, Chung S, Kim KM, Jung KC, Park C, Hahm ER, Yang CH.
    Biochim Biophys Acta; 2004 Feb 24; 1670(3):217-28. PubMed ID: 14980448
    [Abstract] [Full Text] [Related]

  • 3. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ, Gubbels JM, Bernards R, van der Vliet PC, Timmers HT.
    Nucleic Acids Res; 1997 Apr 15; 25(8):1493-501. PubMed ID: 9162900
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S, Peña A, Korcz A, Soprano DR, Soprano KJ.
    Oncogene; 1996 Feb 01; 12(3):621-9. PubMed ID: 8637719
    [Abstract] [Full Text] [Related]

  • 5. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex.
    Peña A, Reddy CD, Wu S, Hickok NJ, Reddy EP, Yumet G, Soprano DR, Soprano KJ.
    J Biol Chem; 1993 Dec 25; 268(36):27277-85. PubMed ID: 8262968
    [Abstract] [Full Text] [Related]

  • 6. Low molecular weight inhibitors of Myc-Max interaction and function.
    Yin X, Giap C, Lazo JS, Prochownik EV.
    Oncogene; 2003 Sep 18; 22(40):6151-9. PubMed ID: 13679853
    [Abstract] [Full Text] [Related]

  • 7. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.
    Blackwood EM, Eisenman RN.
    Science; 1991 Mar 08; 251(4998):1211-7. PubMed ID: 2006410
    [Abstract] [Full Text] [Related]

  • 8. CDC6 interacts with c-Myc to inhibit E-box-dependent transcription by abrogating c-Myc/Max complex.
    Takayama M, Taira T, Iguchi-Ariga SM, Ariga H.
    FEBS Lett; 2000 Jul 14; 477(1-2):43-8. PubMed ID: 10899308
    [Abstract] [Full Text] [Related]

  • 9. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS, Gyuris J, Brent R.
    Cell; 1993 Jan 29; 72(2):223-32. PubMed ID: 8425219
    [Abstract] [Full Text] [Related]

  • 10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K, Anand G, Yin X, Grove L, Prochownik EV.
    Oncogene; 1998 Mar 05; 16(9):1149-59. PubMed ID: 9528857
    [Abstract] [Full Text] [Related]

  • 11. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L, Gaubatz S, Eilers M.
    Genes Dev; 1996 Feb 15; 10(4):447-60. PubMed ID: 8600028
    [Abstract] [Full Text] [Related]

  • 12. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
    Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B.
    Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional activation by Myc is under negative control by the transcription factor AP-2.
    Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M.
    EMBO J; 1995 Apr 03; 14(7):1508-19. PubMed ID: 7729426
    [Abstract] [Full Text] [Related]

  • 14. Mnt-Max to Myc-Max complex switching regulates cell cycle entry.
    Walker W, Zhou ZQ, Ota S, Wynshaw-Boris A, Hurlin PJ.
    J Cell Biol; 2005 May 09; 169(3):405-13. PubMed ID: 15866886
    [Abstract] [Full Text] [Related]

  • 15. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M, Isselbacher KJ, Bernards R.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2739-43. PubMed ID: 8464883
    [Abstract] [Full Text] [Related]

  • 16. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif.
    Hurlin PJ, Steingrìmsson E, Copeland NG, Jenkins NA, Eisenman RN.
    EMBO J; 1999 Dec 15; 18(24):7019-28. PubMed ID: 10601024
    [Abstract] [Full Text] [Related]

  • 17. Specificity of DNA binding of the c-Myc/Max and ARNT/ARNT dimers at the CACGTG recognition site.
    Swanson HI, Yang JH.
    Nucleic Acids Res; 1999 Aug 01; 27(15):3205-12. PubMed ID: 10454619
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
    Wang Z, Ge L, Wang M, Carr BI.
    J Cell Physiol; 2006 Jul 01; 208(1):133-40. PubMed ID: 16596619
    [Abstract] [Full Text] [Related]

  • 19. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.
    Nair SK, Burley SK.
    Cell; 2003 Jan 24; 112(2):193-205. PubMed ID: 12553908
    [Abstract] [Full Text] [Related]

  • 20. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H.
    Cell; 1993 Jan 29; 72(2):233-45. PubMed ID: 8425220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.